Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...

Adam S. Wenick, MD, PhD, chaired a symposium on geographic atrophy (GA) at EyeCon 2024, focusing on the diagnosis, monitoring ...

Proviant Therapeutics announced the first patients have been enrolled in CLARITY, its phase 3 study ( NCT06431373) evaluating ...

In a study, a team of Chinese researchers looked at the mechanisms behind the development of EI and explored effective ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

During a presentation at EyeCon 2024, Jennifer Loh, MD, of Loh Ophthalmology Associates in Miami, Florida, discussed advances ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive ...